TALAVE in Breast Cancer: <i>BRCA1/2</i> Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement
- DOI
- 10.64898/2026.09.17.752386
- Published
- 2026-09-18
- Container
- Not recorded
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.09.17.752386,
title = {TALAVE in Breast Cancer: <i>BRCA1/2</i> Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement},
author = {Lynce F and Shimada K and Isaacs C and Geng X and Richardson ET and Nelson A and Mainor C and Wei M and Collins JM and Pohlmann PR and Heeke AL and Zheng KF and Townsend MG and Swanson N and Sloat LM and Staunton J and Schnitt SJ and Wang H and Brugge JS and Shapiro GI and Guerriero JL.},
year = {2026},
doi = {10.64898/2026.09.17.752386},
url = {https://doi.org/10.64898/2026.09.17.752386}
}RIS
TY - JOUR TI - TALAVE in Breast Cancer: <i>BRCA1/2</i> Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement AU - Lynce F AU - Shimada K AU - Isaacs C AU - Geng X AU - Richardson ET AU - Nelson A AU - Mainor C AU - Wei M AU - Collins JM AU - Pohlmann PR AU - Heeke AL AU - Zheng KF AU - Townsend MG AU - Swanson N AU - Sloat LM AU - Staunton J AU - Schnitt SJ AU - Wang H AU - Brugge JS AU - Shapiro GI AU - Guerriero JL. PY - 2026 DO - 10.64898/2026.09.17.752386 UR - https://doi.org/10.64898/2026.09.17.752386 ER -
APA
F, L., K, S., C, I., X, G., ET, R., A, N., C, M., M, W., JM, C., PR, P., AL, H., KF, Z., MG, T., N, S., LM, S., J, S., SJ, S., H, W., JS, B., GI, S., & JL., G. (2026). TALAVE in Breast Cancer: <i>BRCA1/2</i> Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement. https://doi.org/10.64898/2026.09.17.752386
Source records
- europe-pmc · retrieved 2026-09-25T05:05:30.642Z